Depression drug trial halted early – what happened?

NCT ID NCT06618118

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine called fosigotifator for adults with major depressive disorder. The goal was to see if it is safe and helps with depression symptoms. About 20 people were enrolled before the study was stopped early. Participants took either the drug or a placebo, and researchers checked for side effects and mood changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CenExel CNR /ID# 265866

    Sherman Oaks, California, 91403, United States

  • CenExel iResearch, LLC /ID# 265886

    Decatur, Georgia, 30030-3440, United States

  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 265060

    Orlando, Florida, 32801, United States

  • Northwest Clinical Research Center /ID# 265057

    Bellevue, Washington, 98007, United States